PYC - General Discussion, page-677

Yes that's the game plan and there appears no end of options, it's just picking out the most appropriate ones that best meet the companies goals.

It's becoming more apparent as the data keeps coming in that the delivery platform, the real key behind PYC is going to be a winner, but we're at that important pivotal stage in the coming months where this will be closer to validation, from there the world is our oyster.

Personally i don't think we will get massive improvement in the SP until we get our next period of financing sorted, and to be honest I don't mind the SP lagging a bit as i would prefer a licensing or BD over a capital raise which is highly unlikely with the SP so low, i think if they farm out one of their assets or do a BD on the PKD which is more likely in my eyes the important investors at the big end of town with all the coin will take note a lot more as no doubt they would take comfort that there's other big pharma or corporations in this field confident enough to put money and expertise into the asset helping to further validate it.

I'm guestimating second Qtr 25 for some form of BD, although RH did mention that they were financed to 2026 which going on there current spend and im sure its not getting less it's highly unlikely they can't wait that long, we will see.

So for now i feel its "Patience Grasshoper" which is hard as i'm sure we're all chomping at the bit with excitement and anticipation as it seems so close but so far, especially for those that have been on the journey for many year, it's not only going to be life changing for the patience involved which is the main goal, but i'm sure many of us investors with lot on the line and looking for the possabilty of a very comfortable retirement.